| Novel zebrafish EAE model: A quick in vivo screen for multiple sclerosis P Kulkarni, S Yellanki, R Medishetti, D Sriram, U Saxena, P Yogeeswari Multiple sclerosis and related disorders 11, 32-39, 2017 | 31 | 2017 |
| Ligand/PTC-free intramolecular Heck reaction: synthesis of pyrroloquinoxalines and their evaluation against PDE4/luciferase/oral cancer cell growth in vitro and zebrafish in vivo PV Babu, S Mukherjee, GS Deora, KS Chennubhotla, R Medisetti, ... Organic & Biomolecular Chemistry 11 (39), 6680-6685, 2013 | 28 | 2013 |
| NaSH in the construction of thiophene ring fused with N-heterocycles: A rapid and inexpensive synthesis of novel small molecules as potential inducers of apoptosis SK Kolli, A Nakhi, R Medishetti, S Yellanki, P Kulkarni, RR Raju, M Pal Bioorganic & Medicinal Chemistry Letters 24 (18), 4460-4465, 2014 | 21 | 2014 |
| Ligand-free MCR for linking quinoxaline framework with a benzimidazole nucleus: a new strategy for the identification of novel hybrid molecules as potential inducers of apoptosis R Sunke, PV Babu, S Yellanki, R Medishetti, P Kulkarni, M Pal Organic & Biomolecular Chemistry 12 (35), 6800-6805, 2014 | 21 | 2014 |
| Ruthenium-catalyzed synthesis of pyrrolo [1, 2-a] quinoxaline derivatives from 1-(2-aminophenyl) pyrroles and sulfoxonium ylides XF Cui, FP Hu, XQ Zhou, ZZ Zhan, GS Huang Synlett 31 (12), 1205-1210, 2020 | 19 | 2020 |
| A Pd (II)-catalyzed C–H activation approach to densely functionalized N-heteroaromatics related to neocryptolepine and their evaluation as potential inducers of apoptosis M AshrafáAshfaq, EVVS Ramarao RSC Advances 5 (56), 44722-44727, 2015 | 19 | 2015 |
| Design, Synthesis and Evaluation of 5-pyridin-4-yl-2-thioxo-[1, 3, 4] oxadiazol-3-yl Derivatives as Anti-angiogenic Agents Targeting VEGFR-2 U Bhanushali, S Kalekar-Joshi, R Kulkarni-Munshi, S Yellanki, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2017 | 18 | 2017 |
| Zebrafish based strategy for the identification of a potential pharmacophore for apoptosis: a greener CuAAC approach for novel 1, 2, 3-triazoles derived from mefenamic acid PV Babu, S Mukherjee, DR Gorja, S Yellanki, R Medisetti, P Kulkarni, ... RSC Advances 4 (10), 4878-4882, 2014 | 18 | 2014 |
| Pd-catalyzed isocyanide insertion/nucleophilic attack by indole C-3/desulfonylation in the same pot: A direct access to indoloquinolines of pharmacological interest S BabuáNallapati, S KumaráKolli, A KumaráSharma RSC advances 5 (77), 62966-62970, 2015 | 17 | 2015 |
| Gyrase ATPase Domain as an Antitubercular Drug Discovery Platform: Structure‐Based Design and Lead Optimization of Nitrothiazolyl Carboxamide Analogues VU Jeankumar, J Renuka, S Kotagiri, S Saxena, SS Kakan, JP Sridevi, ... ChemMedChem 9 (8), 1850-1859, 2014 | 16 | 2014 |
| Isovanillin derived N-(un) substituted hydroxylamines possessing an ortho-allylic group: valuable precursors to bioactive N-heterocycles B Dulla, ND Tangellamudi, S Balasubramanian, S Yellanki, R Medishetti, ... Organic & Biomolecular Chemistry 12 (16), 2552-2558, 2014 | 15 | 2014 |
| A Pd-based regioselective strategy to indole-1, 2-fused 8-and 9-membered rings: their evaluation as potential scaffolds for apoptosis in zebrafish B Prasad, BY Sreenivas, A Sushma, S Yellanki, R Medisetti, P Kulkarni, ... Organic & Biomolecular Chemistry 12 (18), 2864-2868, 2014 | 14 | 2014 |
| Correlation of pharmacokinetics and brain penetration data of adult zebrafish with higher mammals including humans P Kulkarni, R Medishetti, N Nune, S Yellanki, V Sripuram, P Rao, D Sriram, ... Journal of Pharmacological and Toxicological Methods 88, 147-152, 2017 | 11 | 2017 |
| Replacement of cardiotoxic aminopiperidine linker with piperazine moiety reduces cardiotoxicity? Mycobacterium tuberculosis novel bacterial topoisomerase inhibitors KA Bobesh, J Renuka, RR Srilakshmi, S Yellanki, P Kulkarni, ... Bioorganic & Medicinal Chemistry 24 (1), 42-52, 2016 | 8 | 2016 |
| Magnetic nanoparticle formulation for targeted delivery of chemotherapeutic irinotecan to lungs P Kulkarni, M Rajadurai, A Sevilimedu, S Basaveni, S Yellanki, ... Drug Delivery and Translational Research 8, 1450-1459, 2018 | 7 | 2018 |
| Ligand-free Pd-catalyzed C–N cross-coupling/cyclization strategy: An unprecedented access to 1-thienyl pyrroloquinoxalines for the new approach towards apoptosis SK Kolli, A Nakhi, S Archana, M Saridena, GS Deora, S Yellanki, ... European Journal of Medicinal Chemistry 86, 270-278, 2014 | 7 | 2014 |
| Red Fluorescent Organic Nanoparticle Bioprobes: A Photostable Cytoplasmic Stain for Long Term In Vitro and In Vivo Visualization ER Reddy, S Yellanki, R Medishetty, L Konada, NP Alamuru, D Haldar, ... ChemNanoMat 1 (8), 567-576, 2015 | 4 | 2015 |
| Double PEGylation Significantly Improves Pharmacokinetic Properties of Irinotecan Containing Nanoparticles in a Zebrafish Model U Saxena, M Rajadurai, S Basaveni, S Yellanki, R Medishetti, ... Current Nanomedicine (Formerly: Recent Patents on Nanomedicine) 9 (2), 173-181, 2019 | 2 | 2019 |
| Zebra Fish Pharmacokinetic Studies R Medishetti, V Sripuram, S Yellanki, P Rao, K Chatti, S Oruganti, ... Indian Journal of Pharmacology 45, S251-S251, 2013 | 2 | 2013 |
| Corrigendum to: Double PEGylation Significantly Improves Pharmacoki-netic Properties of Irinotecan Containing Nanoparticles in a Zebrafish Model U Saxena, M Rajadurai, S Basaveni, S Yellanki, R Medishetti, ... Current Nanomedicine (Formerly: Recent Patents on Nanomedicine) 11 (2), 139-139, 2021 | | 2021 |
